Project Statistics: DESARROLLO DE UN ESTUDIO SOBRE "EVALUACIÓN DE LOS EFECTOS DE LOS INHIBIDORES DE RECEPTORES DE LA TIROSÍN-KINASA EN SARCOMAS CANINOS ESPONTÁNEOS DE ALTO GRADO COMO MODELO PARA SU APLICACIÓN EN PACIENTES HUMANOS", de fecha 5 de abril de 2013
Geo Map
Region
#
NA - North America
56
AS - Asia, other
31
EU - Europe
22
Unknown
27
Total
136
Country
#
US - United States of America
56
SG - Singapore
27
ES - Spain
13
RU - Russian Federation
5
CN - China
3
SE - Sweden
2
DE - Germany
1
KR - Korea
1
TR - Turkey
1
Unknown
27
Total
136
City
#
Arrecife
8
Santa Brigida
5
Singapore
4
Shanghai
2
Ankara
1
Ashburn
1
Hefei
1
Moscow
1
Prineville
1
Santa Clara
1
other
111
Total
136
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2021
0 0
0 0 0 0
8 0 0 2
0 2
12
2022
0 0
5 0 0 1
1 0 0 0
0 0
7
2023
0 0
1 0 0 0
0 0 0 0
0 0
1
2024
8 0
0 0 4 2
12 3 9 6
6 4
54
2025
5 15
0 0 0 6
1 11 0 3
1 5
47
2026
6 1
4 3 1 0
0 0 0 0
0 0
15
Ever
136
Geo Map
| Region | # |
|---|---|
| NA - North America | 56 |
| AS - Asia, other | 31 |
| EU - Europe | 22 |
| Unknown | 27 |
| Total | 136 |
| Country | # |
|---|---|
| US - United States of America | 56 |
| SG - Singapore | 27 |
| ES - Spain | 13 |
| RU - Russian Federation | 5 |
| CN - China | 3 |
| SE - Sweden | 2 |
| DE - Germany | 1 |
| KR - Korea | 1 |
| TR - Turkey | 1 |
| Unknown | 27 |
| Total | 136 |
| City | # |
|---|---|
| Arrecife | 8 |
| Santa Brigida | 5 |
| Singapore | 4 |
| Shanghai | 2 |
| Ankara | 1 |
| Ashburn | 1 |
| Hefei | 1 |
| Moscow | 1 |
| Prineville | 1 |
| Santa Clara | 1 |
| other | 111 |
| Total | 136 |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 2 | 0 | 2 | 12 |
| 2022 | 0 | 0 | 5 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 7 |
| 2023 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2024 | 8 | 0 | 0 | 0 | 4 | 2 | 12 | 3 | 9 | 6 | 6 | 4 | 54 |
| 2025 | 5 | 15 | 0 | 0 | 0 | 6 | 1 | 11 | 0 | 3 | 1 | 5 | 47 |
| 2026 | 6 | 1 | 4 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 |
| Ever | 136 | ||||||||||||